membrane oxygenation (ECMO) is a life support technique used to support
patients with severe respiratory or cardiac failure. The indications for ECMO
can vary depending on the patient’s condition but generally include:
respiratory failure: ECMO may be used for patients who are not responding to
mechanical ventilation or other treatments for severe respiratory failure, such
as acute respiratory distress syndrome (ARDS), pneumonia, or pulmonary
shock: ECMO may be used for patients with severe
heart failure or cardiogenic shock, a condition in which the heart cannot pump enough blood to meet the body’s needs.
transplant: ECMO can be used as a bridge to
transplant for patients who are waiting for a lung or heart transplant and are
shock: ECMO may be used in patients who develop
shock after cardiac surgery, particularly in those with pre-existing cardiac or
Trauma: ECMO may be used for patients with severe lung or heart injury due
hypertension: ECMO may be used for patients with
severe pulmonary hypertension, a condition in which the blood pressure in the
lungs is elevated and can lead to right heart failure.
poisoning: ECMO may be used in cases of drug
overdose or poisoning, in which the patient’s lungs or heart may be
The decision to
use ECMO is made by a team of medical professionals, including critical care
specialists, pulmonologists, and cardiothoracic surgeons, who will evaluate the
patient’s condition and determine if the potential benefits of ECMO outweigh
the risks. ECMO is a complex and expensive procedure that requires specialized
training and expertise and is typically reserved for patients who are
critically ill and not responding to other treatments.
ECMO in Covid
(extracorporeal membrane oxygenation) has been used as a treatment for severe
cases of COVID-19, particularly in patients with acute respiratory distress
syndrome (ARDS) who are not responding to conventional treatments. ECMO can
provide respiratory and cardiac support to patients with severe lung damage and
low oxygen levels.
The use of ECMO
during COVID-19 has been associated with some promising outcomes in select
patients, although it is not a suitable treatment for all patients with severe
COVID-19. ECMO is a highly invasive and complex procedure requiring specialised equipment and highly trained medical professionals. As a
result, it is typically reserved for critically ill patients who have not
responded to other treatments.
associated with a number of risks and potential complications, including
bleeding, infection, and damage to the blood vessels. Patients who receive ECMO
during COVID-19 require close monitoring, and the decision to use ECMO is
typically made on a case-by-case basis, taking into account the patient’s
individual clinical condition, overall health, and other factors.
In some cases,
ECMO may be used as a bridge to other treatments, such as lung transplantation
or recovery. It is important to note that ECMO is not a cure for COVID-19, and
patients who receive ECMO may require additional treatment and support after
they have been weaned off the machine.
The use of ECMO
(extracorporeal membrane oxygenation) has increased in recent times,
particularly during the COVID-19 pandemic. ECMO has been used as a treatment
for severe respiratory failure in patients with COVID-19 who are not responding
to conventional treatments. During the pandemic, there has been a significant
increase in the number of patients with severe respiratory failure,
particularly those with acute respiratory distress syndrome (ARDS) associated
with COVID-19. ECMO has been used in some of these patients as a last-resort
treatment option, and there have been reports of positive outcomes, including
improved survival rates and reduced need for mechanical ventilation.
(extracorporeal membrane oxygenation) has been associated with good outcomes in
certain patients with severe respiratory and/or cardiac failure. The use of
ECMO is typically reserved for critically ill patients who have not responded
to conventional treatments, and it can be a life-saving intervention in some
One example of a
condition where ECMO has been associated with good outcomes is acute
respiratory distress syndrome (ARDS), which is a severe lung injury that can be
caused by a variety of factors, including infections, trauma, and other
conditions. ECMO has been used as a treatment for severe ARDS, and studies have
shown that it can improve survival rates and reduce the risk of complications.
ECMO has also
been used in patients with severe cardiac failure, such as those with
cardiogenic shock or cardiac arrest. In these cases, ECMO can provide temporary
support to the heart and circulatory system, allowing the heart to rest and
heal. Studies have shown that ECMO can effectively improve survival rates and reduce the risk of complications in these patients.
Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.
GIPHY App Key not set. Please check settings